U.S. Department of Health and Human Services

Chronic Kidney Disease

The Chronic Kidney Disease program supports basic, translational, and clinical research.  The program includes studies to improve diagnosis and understand the functional adaptation to nephron loss.  The program also advances studies that identify and test possible therapeutic interventions to prevent development or halt progression of renal disease.​​​​​​​​​​​​​​​​​​​​​​​​​​

 NIDDK Staff

Kevin Abbott, M.D., M.P.H.Kidney and Urology Epidemiology; Transplant; DialysisMichael Flessner, M.D., Ph.D.Clinical CKD; Glomerular Disease; Clinical PKD; PKD CentersJohn W. Kusek, Ph.D.Kidney and Urology Clinical Trials
Andrew Narva, M.D.​Kidney Translation; Director, National Kidney Disease Education Program (NKDEP) Krystyna Rys-Sikora, Ph.D.Basic AKI and CKD


 Related Funding Opportunities

Posted DateTitleFull Announcement
11/20/2015Advancing Erythroid Cell Biology (R01) (Summary) PA-16-039
11/20/2015Psychosocial and Behavioral Mechanisms in Bariatric Surgery (R01) (Summary) RFA-DK-16-017
11/6/2015Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01) (Summary) PAR-16-034
11/3/2015Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01) (Summary) RFA-DK-16-014
11/3/2015Innovative Research in HIV in Kidney, Urology, and Hematology (R01) (Summary) RFA-DK-16-015
View More Funding Opportunities

The resources listed below include reagents, data, protocols, etc. If you would like to utilize any of these resources, contact the person associated with the resource.


 Research Resources

Resource NameDescription
Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
Action for Health in Diabetes
Look AHEAD is a 16-center, randomized clinical trial investigating the long-term health effects of an intensive lifestyle intervention designed to produce weight loss. Look AHEAD enrolled 5,145 overweight or obese participants with type 2 diabetes…
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…
Lifestyle Interventions for Expectant Moms

LIFE-Moms is a consortium comprised of seven clinical centers, a Research Coordinating Unit and NIH program staff.  The overall goal of the Consortium is to identify effective behavioral and lifestyle interventions that will improve weight, glycemic…

Hyperglycemia and Pregnancy Outcomes Follow-Up Study Consortium

The goal of this follow-up study of mothers who participated in the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study, is to determine the levels of blood sugar during pregnancy that are linked to increased body fat in the child, and to a…

View Additional Research Resources


 NIDDK Active Trials in Chronic Kidney Disease

View related clinical trials from ClinicalTrials.gov.


 Related Study Sections

Study sections conduct initial peer review of applications in a designated scientific area.
View related study sections from the NIH's Center for Scientific Review.